Neogene Therapeutics
Cell therapy company developing personalized neoantigen-targeting T cell receptor (TCR) therapies for solid tumors. Acquired by AstraZeneca in 2022 for up to $320 million.
Website
https://www.neogene.comLocation
Los Angeles, California, USA & Amsterdam, Netherlands
Founded
2019
Investors
1
Categories
biotech, cell-therapy, oncology, tcr-therapy, personalized-medicine
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Polaris Partners | US | biotech-focused | - | 33 |